Stockhead’s Fraser Palamara sits down with new Race Oncology (ASX:RAC) executive chair Dr Peter Smith to get the short end of the long story on the company’s latest news.

A board rework has been taken by investors in great stride, and Dr Smith goes over the company’s evolution, why the changes were made, and how RAC’s highly credentialed leadership is now placed to tackle its noble mission in the fight against cancer.

 

This video was developed in collaboration with Race Oncology, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.